BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23065504)

  • 1. Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach.
    Iolascon A; Esposito MR; Russo R
    Haematologica; 2012 Dec; 97(12):1786-94. PubMed ID: 23065504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital dyserythropoietic anemias.
    Iolascon A; Russo R; Delaunay J
    Curr Opin Hematol; 2011 May; 18(3):146-51. PubMed ID: 21378561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic phenotypes associated with congenital dyserythropoietic anemia (type II) manifest at different stages of erythropoiesis.
    Satchwell TJ; Pellegrin S; Bianchi P; Hawley BR; Gampel A; Mordue KE; Budnik A; Fermo E; Barcellini W; Stephens DJ; van den Akker E; Toye AM
    Haematologica; 2013 Nov; 98(11):1788-96. PubMed ID: 23935019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of congenital dyserythropoietic anemias.
    Gambale A; Iolascon A; Andolfo I; Russo R
    Expert Rev Hematol; 2016 Mar; 9(3):283-96. PubMed ID: 26653117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital dyserythropoietic anemias: molecular insights and diagnostic approach.
    Iolascon A; Heimpel H; Wahlin A; Tamary H
    Blood; 2013 Sep; 122(13):2162-6. PubMed ID: 23940284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Novel Mutation in the SEC23B Gene Associated With Congenital Dyserythropoietic Anemia Type II Through the Use of Next-generation Sequencing Panel in an Undiagnosed Case of Nonimmune Hereditary Hemolytic Anemia.
    Aydin Koker S; Karapinar TH; Oymak Y; Bianchi P; Fermo E; Gozmen S; Vergin C
    J Pediatr Hematol Oncol; 2018 Oct; 40(7):e421-e423. PubMed ID: 29846281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital dyserythropoietic anemia.
    Kamiya T; Manabe A
    Int J Hematol; 2010 Oct; 92(3):432-8. PubMed ID: 20820969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis.
    Heimpel H
    Ann Hematol; 2004 Oct; 83(10):613-21. PubMed ID: 15278299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated.
    Noy-Lotan S; Dgany O; Lahmi R; Marcoux N; Krasnov T; Yissachar N; Ginsberg D; Motro B; Resnitzky P; Yaniv I; Kupfer GM; Tamary H
    Haematologica; 2009 May; 94(5):629-37. PubMed ID: 19336738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia type II.
    Unal S; Russo R; Gumruk F; Kuskonmaz B; Cetin M; Sayli T; Tavil B; Langella C; Iolascon A; Uckan Cetinkaya D
    Pediatr Transplant; 2014 Jun; 18(4):E130-3. PubMed ID: 24724984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship.
    Iolascon A; Russo R; Esposito MR; Asci R; Piscopo C; Perrotta S; Fénéant-Thibault M; Garçon L; Delaunay J
    Haematologica; 2010 May; 95(5):708-15. PubMed ID: 20015893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The congenital dyserythropoietic anemias.
    Renella R; Wood WG
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):283-306. PubMed ID: 19327584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II.
    Schwarz K; Iolascon A; Verissimo F; Trede NS; Horsley W; Chen W; Paw BH; Hopfner KP; Holzmann K; Russo R; Esposito MR; Spano D; De Falco L; Heinrich K; Joggerst B; Rojewski MT; Perrotta S; Denecke J; Pannicke U; Delaunay J; Pepperkok R; Heimpel H
    Nat Genet; 2009 Aug; 41(8):936-40. PubMed ID: 19561605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1{alpha} localization in erythroblasts.
    Renella R; Roberts NA; Brown JM; De Gobbi M; Bird LE; Hassanali T; Sharpe JA; Sloane-Stanley J; Ferguson DJ; Cordell J; Buckle VJ; Higgs DR; Wood WG
    Blood; 2011 Jun; 117(25):6928-38. PubMed ID: 21364188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Very Rare Congenital Dyserythropoietic Anemia Variant-Type IV in a Patient With a Novel Mutation in the KLF1 Gene: A Case Report and Review of the Literature.
    Belgemen-Ozer T; Gorukmez O
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):e536-e540. PubMed ID: 32032242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Close to unraveling the secrets of congenital dyserythropoietic anemia types I and II.
    Iolascon A; Delaunay J
    Haematologica; 2009 May; 94(5):599-602. PubMed ID: 19407313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extra medullary hematopoiesis associated to congenital dyserythropoietic anemia II in adult].
    Jedidi I; Medhaffar M; Ghorbel M; Hdiji S; Makni F; Elloumi M; Kallel C
    Ann Biol Clin (Paris); 2012; 70(2):217-20. PubMed ID: 22484535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VPS4A Mutations in Humans Cause Syndromic Congenital Dyserythropoietic Anemia due to Cytokinesis and Trafficking Defects.
    Seu KG; Trump LR; Emberesh S; Lorsbach RB; Johnson C; Meznarich J; Underhill HR; Chou ST; Sakthivel H; Nassar NN; Seu KJ; Blanc L; Zhang W; Lutzko CM; Kalfa TA
    Am J Hum Genet; 2020 Dec; 107(6):1149-1156. PubMed ID: 33186543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lethal hydrops fetalis due to congenital dyserythropoietic anemia in a newborn: association of a new skeletal abnormality.
    Tekinalp G; Sarici SU; Erdinç AS; Gögüş S; Balci S; Gürgey A
    Pediatr Hematol Oncol; 2001 Dec; 18(8):537-42. PubMed ID: 11764104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective cohort study of 205 cases with congenital dyserythropoietic anemia type II: definition of clinical and molecular spectrum and identification of new diagnostic scores.
    Russo R; Gambale A; Langella C; Andolfo I; Unal S; Iolascon A
    Am J Hematol; 2014 Oct; 89(10):E169-75. PubMed ID: 25044164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.